Aug
TL;DR: Facial balancing means assessing the whole face, bone, fat, muscle, and skin, before choosing any product, then treating proportions with the minimum amount that does the job. It’s the opposite of chasing one feature with repeat syringes. Often the real structural deficit sits at the chin or jawline, where the skeleton loses support with age. Combination plans also held correction longer in trial data, 32 weeks versus 18 for filler alone. Meanwhile, MRI shows filler persists for years, so stacking product is exactly how faces get overdone. If a clinic’s answer to every concern is another syringe of the same thing, keep looking.
US clinicians performed 5,331,426 hyaluronic acid filler procedures and 9,883,711 neuromodulator treatments in 2024 (American Society of Plastic Surgeons, US data). That’s a lot of syringes. Yet the most common problem I see in consultation isn’t too little product; it’s product aimed at the wrong place. Someone asks for a third lip syringe when the real issue is a receded chin. Someone chases their nasolabial folds while the midface quietly deflates above them. I’m Dr. Dusan Sajic, a dermatologist at deRMA Skin Institute in Guelph, and this article explains the alternative: facial balancing. It’s the concept behind my whole approach to injectables, and it starts with a rule that sounds odd coming from someone who injects for a living: more filler is usually not the answer.
Key Takeaways
- CT studies show the facial skeleton remodels throughout life: key angles decrease, the orbital aperture widens, and the midface loses projection (Shaw & Kahn, Plastic and Reconstructive Surgery, 2007). Aging proportions are a structural issue, not just a skin issue.
- Balanced plans hold up: neuromodulator plus filler maintained glabellar correction about 32 weeks versus 18 weeks for filler alone in a randomized trial of 38 patients (Dermatologic Surgery, 2003).
- Restraint is evidence-based: MRI found HA filler in all 33 scanned patients two or more years after injection, up to 15 years (PRS Global Open, 2024), and overfilled face syndrome now has a formal clinical classification (2025 framework).
- Injector choice moves the safety numbers: vascular occlusion occurred about once per 6,410 syringes with needles versus once per 40,882 with cannulas (JAMA Dermatology, 2021), and the nose was involved in 40.6% of published filler-blindness cases (Aesthetic Surgery Journal, 2024).
Facial balancing is a treatment philosophy that assesses the whole face, skeletal support, fat compartments, muscle activity, and skin quality, before any product is chosen, then treats proportions rather than individual wrinkles or features. Instead of asking “what do we put in the lips,” it asks why the lips read the way they do; often the answer sits at the chin, the jawline, or the midface. The approach matters because injectables are now mainstream medicine: US clinicians performed 5,331,426 hyaluronic acid filler procedures in 2024 alone (American Society of Plastic Surgeons, US data). Volume without a proportional plan is how faces drift toward “done.” Balanced treatment typically means several small, deliberate placements across the face, and sometimes different tools entirely, in place of repeated syringes into one area. The goal isn’t a new face. It’s your face, with the structural support it used to have, using the minimum effective amount of product.
So is this just a rebrand for getting lots of filler everywhere? The opposite, actually. However, the distinction only makes sense once you see why proportions drift in the first place.
Because the framework changes underneath. CT comparisons of younger and older adults show the facial skeleton keeps remodelling throughout life: the glabellar and maxillary angles decrease, the orbital aperture widens, and the midface loses projection (Shaw & Kahn, Plastic and Reconstructive Surgery, 2007). Soft tissue can only drape what the bone still supports.
A widely cited review describes the same pattern: the skeleton behaves like a scaffold that recedes in specific zones rather than staying fixed (Mendelson & Wong, Aesthetic Plastic Surgery). Consequently, a chin that “was never there,” or a jawline that faded through your 40s, is usually a skeletal-support issue. That’s precisely the kind of deficit modern dermal fillers are designed to address.
Facial fat isn’t one continuous sheet. Cadaver research showed it sits in discrete, independent compartments (Rohrich & Pessa, Plastic and Reconstructive Surgery, 2007). With age, midfacial compartments migrate downward and the deep medial cheek fat deflates (Gierloff, Plastic and Reconstructive Surgery, 2012, a small 12-cadaver imaging study worth reading with that caveat). Clinically, this is why single-point “cheek filler” without compartment thinking can look strange: product lands in a compartment that never needed it. Rapid weight loss can speed the deflation up, too; I covered that in my piece on GLP-1 weight loss and facial aging.
Right at the centre of most balancing plans. Chin filler is dermal filler placed to restore forward projection and height at the chin; jawline filler rebuilds definition along the border of the jaw. Both address support the skeleton no longer provides, the same lower-face changes described in the skeletal aging literature (Mendelson & Wong). In my experience, the chin is the most under-assessed feature I see in consultation: patients study their lips and folds while the actual proportional deficit sits just below.
How do you know if your concern is really a proportion problem? A few patterns come up constantly:
Does any of that mean filler is automatic? No. Sometimes the honest recommendation is a different modality, or nothing yet. That said, when structure is the issue, supporting the chin and jaw often does more for overall harmony than another syringe anywhere else.
Because filler doesn’t leave on schedule. MRI research found HA filler still detectable in all 33 scanned patients two or more years after mid-face injection, and in some cases up to 15 years later (PRS Global Open, 2024). Add a “refresh” on top of persistent product every six months and volume compounds quietly, year after year.
The endpoint of that math now has a name. Overfilled face syndrome, the heavy, puffy, oddly uniform look of accumulated filler, has been formally described in a 2025 clinical classification framework (Journal of Cosmetic Medicine classification, 2025). Sound familiar from your social feed? In our Guelph clinic, we’ve found the antidote is boring and effective: reassess proportions before every top-up, and treat what the face shows today rather than refilling by calendar. The full maintenance logic is in how long fillers really last.
To be clear, this isn’t anti-filler. It’s anti-autopilot.
In trial data, yes. A randomized study of 38 patients found neuromodulator plus HA filler maintained glabellar correction for a median of about 32 weeks, versus 18 weeks for filler alone (Carruthers, Dermatologic Surgery, 2003). Nearly double the maintenance came from pairing tools, not from raising the filler dose.
Why does pairing beat stacking? Each tool does a job the others can’t. Neuromodulators, which in Canada are prescription drugs requiring medical assessment, quiet the muscle activity that folds skin and grinds down product. Fillers restore structure where bone and fat have receded. Meanwhile, biostimulators like Sculptra rebuild broad, gradual support in regions where a firm gel would sit heavy. Consequently, a balanced multi-tool plan often uses less filler than a single-area plan, not more.
By respecting the vascular map and letting it dictate technique. In a study covering roughly 1.66 million syringes injected by board-certified dermatologists, vascular occlusion, filler entering or compressing a blood vessel, occurred about once per 6,410 syringes with needles versus once per 40,882 with blunt cannulas (JAMA Dermatology, 2021). Uncommon either way. Still, a six-fold gap tells you technique is not a detail.
Location matters even more than instrument. Of 511 published cases of filler-related vision loss, the nose was involved in 40.6%, the forehead in 27.7%, and the glabella in 19.0% (Aesthetic Surgery Journal, 2024). Consequently, prevention is the entire strategy: detailed vascular anatomy, conservative product and technique choices in risky zones, and the stocked complication protocol we keep on hand in our Guelph clinic.
That data shapes one conversation in particular. Patients sometimes ask about so-called nonsurgical rhinoplasty, filler used to reshape the nose. I’ll be direct: the nose is the highest-risk site in the published blindness data, so I approach it with extreme caution and often recommend against it. A balancing plan can frequently improve profile proportions at the chin instead, well away from the most dangerous territory.
More measuring than injecting. With US injectable demand above 15 million procedures in 2024 across neuromodulators and HA fillers (American Society of Plastic Surgeons, US data), marketing pressure is everywhere; assessment is the filter. In my practice, facial balancing runs through the same 5-Dimension Skin Plan lens I apply to skin health, examining bone, fat, muscle, and skin together instead of one feature at a time. A typical first visit covers:
In our experience, patients who ask for one syringe in one spot are usually describing a proportion problem, not a volume problem. Sometimes the first step isn’t filler at all.
Facial balancing is whole-face proportion assessment and treatment. Rather than filling one feature, it maps bone, fat, muscle, and skin, then places the minimum effective product where support is missing. It’s a corrective response to a market that hit 5,331,426 US HA filler procedures in 2024 (American Society of Plastic Surgeons, US data).
Visible duration varies by product, placement, and person, but the honest answer is “longer than labels imply.” MRI found HA filler still present two or more years after injection in all 33 scanned patients (PRS Global Open, 2024). Consequently, I reassess before any top-up; details in how long fillers really last.
Serious complications are uncommon and heavily technique-dependent. Vascular occlusion occurred about once per 6,410 syringes with needles versus once per 40,882 with cannulas across roughly 1.66 million syringes injected by board-certified dermatologists (JAMA Dermatology, 2021). Injector qualifications, anatomy knowledge, and an on-site complication protocol are your main safety levers.
Sometimes it’s technically possible; I rarely recommend it. The nose was the single most frequent site in 511 published filler-related vision-loss cases, at 40.6% (Aesthetic Surgery Journal, 2024). In my practice, we usually address profile balance at the chin instead, and reserve nose-area filler for narrow cases after a frank risk conversation.
No. Balancing usually means fewer, more deliberate placements, and sometimes different tools entirely. Combination treatment maintained correction about 32 weeks versus 18 for filler alone in a randomized trial of 38 patients (Dermatologic Surgery, 2003). If every visit ends with more syringes, that’s a menu, not a plan; start with my injectables guide.
Bring photos of yourself from ten years ago if you have them; they’re more useful than any trend. I’ll map your proportions, show you what’s actually changed, and lay out a sequenced plan, including the parts I’d skip. If the right answer is less than you expected, you’ll hear that too. Request a consultation at deRMA Skin Institute in Guelph; we also see patients from Kitchener-Waterloo, Cambridge, and Fergus.
Medically reviewed by Dr. Dusan Sajic, MD, PhD — dermatologist, deRMA Skin Institute, Guelph, ON.
1. American Society of Plastic Surgeons, “2024 Plastic Surgery Statistics Report” (US procedural data), https://www.plasticsurgery.org/documents/news/statistics/2024/plastic-surgery-statistics-report-2024.pdf 2. Shaw RB, Kahn DM, three-dimensional CT study of aging in the facial skeleton, Plastic and Reconstructive Surgery, 2007, https://pubmed.ncbi.nlm.nih.gov/17230106/ 3. Mendelson B, Wong CH, review of changes in the facial skeleton with aging and implications for facial rejuvenation, Aesthetic Plastic Surgery, https://link.springer.com/article/10.1007/s00266-020-01823-x 4. Rohrich RJ, Pessa JE, “The Fat Compartments of the Face,” cadaver anatomy study, Plastic and Reconstructive Surgery, 2007, https://pubmed.ncbi.nlm.nih.gov/17519724/ 5. Gierloff M, et al., CT study of aging changes in the midfacial fat compartments (n=12 cadaveric), Plastic and Reconstructive Surgery, 2012, https://pubmed.ncbi.nlm.nih.gov/21915077/ 6. Carruthers J, Carruthers A, randomized trial of botulinum toxin type A plus hyaluronic acid filler versus filler alone for glabellar rhytids (n=38), Dermatologic Surgery, 2003, https://pubmed.ncbi.nlm.nih.gov/12859378/ 7. Master M, et al., “Hyaluronic Acid Filler Longevity in the Mid-face: A Review of 33 MRI Studies,” PRS Global Open, 2024, https://journals.lww.com/prsgo/fulltext/2024/07000/hyaluronic_acid_filler_longevity_in_the_mid_face_.36.aspx 8. Proposed clinical classification framework for overfilled face syndrome, 2025, https://journals.sagepub.com/doi/10.1177/30499240251376908 9. Alam M, et al., “Rates of Vascular Occlusion Associated With Using Needles vs Cannulas for Filler Injection,” JAMA Dermatology, 2021, https://jamanetwork.com/journals/jamadermatology/fullarticle/2774505 10. Doyon VC, Beleznay K, et al., review of 511 published cases of filler-associated visual loss (1906-2023), Aesthetic Surgery Journal, 2024, https://academic.oup.com/asj/article/44/10/1091/7649223
Dusan Sajic, MD, PhD
Richard Backstein, MD
Sonja Sajic, CCPA
Toni Alberto, CCPA
With more than 20 years of experience, deRMA Skin Institute strive to offer patients the most advanced treatments available to keep their skin healthy and looking its best. Board Certified Dermatologist, Dusan Sajic, MD, PhD, board-certified Plastic and Reconstructive Surgeon, Richard Backstein, MD, FRCSC, Sonja Sajic, CCPA, and Toni Alberto CCPA are committed to providing state-of-the-art medical, surgical and cosmetic treatments to all patients in Guelph, Cambridge, Kitchener, Hamilton, Milton, and surrounding areas.
Fields marked * are required
If you are an existing patient inquiring about appointments and services, please contact
Guelph Cosmetic Department: (888) 803-3762 cosmetic@dermaskininstitute.com
Guelph Medical Department: (519) 836-8558 patientcare@dermaskininstitute.com